Have to eat crow, I was wrong about the results. Typically the price Sky rockets after I sell.
Could this be the Imugene moment for Immutep? IMM is far more advanced with better clinical results. Something has to give. Is the FDA nod of approval all there is ? Are they going to move us up the food chain? They would have been aware of OS results. You would think that in the interests of public health they would be moving this forward as quickly as possible on multiple fronts.
Guess I’ve got to find my way back in before this gets away.
Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC, page-19
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |